These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
271 related items for PubMed ID: 15609328
1. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Cho JA, Yeo DJ, Son HY, Kim HW, Jung DS, Ko JK, Koh JS, Kim YN, Kim CW. Int J Cancer; 2005 Apr 20; 114(4):613-22. PubMed ID: 15609328 [Abstract] [Full Text] [Related]
2. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. Hsu DH, Paz P, Villaflor G, Rivas A, Mehta-Damani A, Angevin E, Zitvogel L, Le Pecq JB. J Immunother; 2003 Apr 20; 26(5):440-50. PubMed ID: 12973033 [Abstract] [Full Text] [Related]
5. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G. Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414 [Abstract] [Full Text] [Related]
6. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models. Cho JA, Lee YS, Kim SH, Ko JK, Kim CW. Cancer Lett; 2009 Mar 18; 275(2):256-65. PubMed ID: 19036499 [Abstract] [Full Text] [Related]
8. Immune selection in murine tumors. Ph.d thesis. Svane IM, Engel AM. APMIS Suppl; 2003 Mar 18; (106):1-46. PubMed ID: 12739251 [Abstract] [Full Text] [Related]
9. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice. Karan D, Dubey S, Van Veldhuizen P, Holzbeierlein JM, Tawfik O, Thrasher JB. Immunotherapy; 2011 Jun 18; 3(6):735-46. PubMed ID: 21668311 [Abstract] [Full Text] [Related]
10. Exosomal cancer immunotherapy is independent of MHC molecules on exosomes. Hiltbrunner S, Larssen P, Eldh M, Martinez-Bravo MJ, Wagner AK, Karlsson MC, Gabrielsson S. Oncotarget; 2016 Jun 21; 7(25):38707-38717. PubMed ID: 27231849 [Abstract] [Full Text] [Related]
11. Antitumor efficacy of interferon-γ-modified exosomal vaccine in prostate cancer. Shi X, Sun J, Li H, Lin H, Xie W, Li J, Tan W. Prostate; 2020 Aug 21; 80(11):811-823. PubMed ID: 32427375 [Abstract] [Full Text] [Related]
13. Immunogenicity of human neuroblastoma. Prigione I, Corrias MV, Airoldi I, Raffaghello L, Morandi F, Bocca P, Cocco C, Ferrone S, Pistoia V. Ann N Y Acad Sci; 2004 Dec 21; 1028():69-80. PubMed ID: 15650233 [Abstract] [Full Text] [Related]